Quantitative Assessment of the Association of COX-2 (Cyclooxygenase-2) Immunoexpression with Prognosis in Human Osteosarcoma: A Meta-Analysis
Authors:
Open Access
- 16 December 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (12) , e82907
Abstract
Numerous studies examining the relationship between Cyclooxygenase-2 (COX-2) immunoexpression and clinical outcome in osteosarcoma patients have yielded inconclusive results. We accordingly conducted a meta-analysis of 9 studies (442 patients) that evaluated the correlation between COX-2 immunoexpression and clinical prognosis (death). Pooled odds ratios (OR) and risk ratios (RR) with 95% confidence intervals (95% CI) were calculated using the random-effects or fixed-effects model. Meta–analysis showed no significant association between COX-2 positivity and age, gender, tumor location, histology, stage, metastasis or 90% necrosis. Conversely, COX-2 immunoexpression was associated with overall survival rate (RR=2.12; 95% CI: 1.10–3.74; P=0.009) and disease-free survival rate (RR=1.63; 95% CI: 1.17–2.28; P=0.004) at 2 years. Sensitivity analysis performed by omitting low quality studies showed that the pooled results were stable. COX-2 positivity was associated with a lower 2-year overall survival rate and disease-free survival rate. COX-2 expression change is an independent prognostic factor in patients with osteosarcoma.Keywords
This publication has 34 references indexed in Scilit:
- Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patientsMedical Oncology, 2013
- Survival Trends and Long-Term Toxicity in Pediatric Patients with OsteosarcomaSarcoma, 2012
- Predicting chemosensitivity in osteosarcoma prior to chemotherapy: An investigational study of biomarkers with immunohistochemistryOncology Letters, 2012
- The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic reviewJournal of Cancer Research and Clinical Oncology, 2012
- Cyclooxygenase-2 Expression and Its Prognostic Significance in Clear Cell Renal Cell CarcinomaThe Korean Journal of Pathology, 2012
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Cyclooxygenase-2 Overexpression Predicts Poor Survival in Patients with High-grade Extremity Osteosarcoma: A Pilot StudyClinical Orthopaedics and Related Research, 2009
- COX-2 Expression Correlates With Survival in Patients With Osteosarcoma Lung MetastasesJournal of Pediatric Hematology/Oncology, 2008
- Expression and clinical significance of OPN and COX-2 in osteosarcomaThe Chinese-German Journal of Clinical Oncology, 2007
- Prognostic Significance of TP53 Tumor Suppressor Gene Expression and Mutations in Human OsteosarcomaClinical Cancer Research, 2004